Enlivex Therapeutics Ltd.
USD0.55
-0.03 (-5.19%)
CEO
Oren Hershkovitz
IPO Date
2014-07-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Open
$0.59
Prev. Close
$0.58
Day Low
$0.54
Day High
$0.59
52W Low
$0.54
52W High
$2.10
Market Cap
$0.01B
Volume
0.38M
| -1.6 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -96.6% | -78.9% | 0.03 | 5.57 | -1.7 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -54.6% | -45.9% | 0.09 | 7.92 | -2.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -17.0% | -15.2% | 0.01 | 18.32 | -7.7 |
| 31 Dec 2020 | FY | -12.6% | -519.3% | -33.3% | -29.3% | 0.01 | 8.72 | -9.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -83.2% | -53.4% | 0.01 | 2.75 | -7.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -50.5% | -44.4% | 0.00 | 9.09 | -0.6 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -188.0% | -164.1% | 0.00 | 7.87 | -1.2 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -184.2% | -150.7% | 0.00 | 5.46 | -1.0 |
| -2.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -9.8% | -8.3% | 0.03 | 6.41 | -3.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -16.7% | -14.4% | 0.02 | 7.20 | -1.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -21.9% | -18.7% | 0.02 | 6.84 | -1.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -9.8% | -8.7% | 0.03 | 9.71 | -3.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -10.8% | -9.7% | 0.03 | 10.06 | -2.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -15.4% | -13.3% | 0.03 | 7.86 | -4.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -30.2% | -24.7% | 0.03 | 5.57 | -1.4 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -15.4% | -12.7% | 0.12 | 7.34 | -1.2 |